Financial statements Namedycyne

Balance sheet of Namedycyne

Company age:
Age:
6 y. 17 d.
Share capital:
Share capital:
10 000 PLN

Balance sheet data of NAMEDYCYNE

Year
2020
2021
2022
2023
Total assets 219 293,94 482 659,83 699 798,46 983 262,41
A. Fixed assets - 0,00 10 562,50 812,50
B. Current assets 219 293,94 482 659,83 689 235,96 982 449,91
C. Share capital contributions (basic funds) - 0,00 0,00 0,00
D. Own shares (stocks) - 0,00 0,00 0,00
Total liabilities 219 396,94 482 659,83 699 798,46 983 262,41
A. Equity 76 739,35 183 075,10 354 837,65 655 107,40
B. Liabilities and provisions for liabilities 142 554,59 299 584,73 344 960,81 328 155,01
I. Long-term liabilities 25 024,66 0,00 0,00 0,00
II. Short-term liabilities 117 529,93 299 584,73 344 960,81 328 155,01
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.